Were the recent Natera (NTRA) CFO share sales under a Rule 10b5-1 plan?

Yes. The filing notes the Rule 10b5-1 checkbox as true, and the August 4, 2026 sale of 478 shares was effected under a Rule 10b5-1 trading plan adopted June 9, 2025 and modified September 10, 2025.

Natera (NTRA) CFO logs 795-share stock sales for taxes and Rule 10b5-1

Q: What insider transactions did Natera (NTRA) disclose for its CFO?

Natera’s CFO, Michael Burkes Brophy , reported selling a total of 795 common shares on August 3 and 4, 2026 , in two separate transactions, both executed under Rule 10b5-1 trading arrangements and related instructions.

Q: How many Natera (NTRA) shares did the CFO sell on each transaction date?

On August 3, 2026 , the CFO sold 317 shares at $267.9893 per share. On August 4, 2026 , he sold 478 shares at $274.22 per share, for an aggregate of 795 shares sold across both days.

Q: Why did Natera’s (NTRA) CFO sell 317 shares on August 3, 2026?

The 317-share sale on August 3, 2026 was executed to satisfy tax withholding and remittance obligations tied to the vesting of RSUs, under a written instruction intended to satisfy Rule 10b5-1(c) affirmative defense conditions.

Q: What role does the insider in this Natera (NTRA) Form 4 hold?

The reporting person, Michael Burkes Brophy , serves as Chief Financial Officer of Natera, Inc. The reported transactions relate to his holdings of Natera common stock and associated RSU vesting tax obligations.

Q: How many total Natera (NTRA) shares were sold by the CFO in this Form 4?

In this Form 4, the CFO is shown selling an aggregate of 795 shares of Natera common stock, consisting of 317 shares sold on August 3, 2026 and 478 shares sold on August 4, 2026.

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Natera, Inc. executive Michael Burkes Brophy, the Chief Financial Officer, reported two sales of common stock totaling 795 shares. On August 3, 2026, he sold 317 shares at $267.9893 per share to satisfy tax withholding and remittance obligations arising from the vesting of RSUs, under a written instruction intended to meet the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. On August 4, 2026, he sold 478 shares at $274.22 per share, with those sales effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025 and modified on September 10, 2025. The filing also checks the Rule 10b5-1 affirmative-defense box, indicating these transactions were executed under Rule 10b5-1 trading arrangements.

Insights

Analyzing...

Insider Trade Summary 10b5-1

Net Seller: 795 shares

Net Sell 2 txns

Insider Brophy Michael Burkes

Role CHIEF FINANCIAL OFFICER

Sold 795 shs ($216K)

Type	Security	Shares	Price	Value
Sale	Common Stock ^F2	478	$274.22	$131K
Sale	Common Stock ^F1	317	$267.9893	$85K

Holdings After Transaction: Common Stock — 51,637 shares (Direct)

Footnotes (2)

F1. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
F2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2025, as modified on September 10, 2025.

Key Figures

Total shares sold: 795 shares Shares sold for RSU tax withholding: 317 shares Price per share on August 3, 2026 sale: $267.9893 +4 more

7 metrics

Total shares sold 795 shares Aggregate across reported sales by the CFO

Shares sold for RSU tax withholding 317 shares Sale on August 3, 2026 to satisfy tax obligations on RSU vesting

Price per share on August 3, 2026 sale $267.9893 Per-share price for the 317-share sale

Shares sold under 10b5-1 plan 478 shares Sale on August 4, 2026 under Rule 10b5-1 trading plan

Price per share on August 4, 2026 sale $274.22 Per-share price for the 478-share sale

Rule 10b5-1 plan adoption date June 9, 2025 Adoption date of the CFO’s trading plan cited for August 4 sale

Rule 10b5-1 plan modification date September 10, 2025 Modification date of the CFO’s Rule 10b5-1 trading plan

Key Terms

Rule 10b5-1 trading plan, tax withholding and remittance obligations, vesting of RSUs, affirmative defense conditions

4 terms

Rule 10b5-1 trading plan regulatory

"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

tax withholding and remittance obligations financial

"The sale of shares was effected in order to satisfy tax withholding and remittance obligations"

vesting of RSUs financial

"in connection with the vesting of RSUs and was made pursuant to a written instruction"

affirmative defense conditions regulatory

"intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/05/2026 - 09:35 PM Accepted by SEC EDGAR 08/05/2026 - 09:35 PM

FAQ

What insider transactions did Natera (NTRA) disclose for its CFO?

Natera’s CFO, Michael Burkes Brophy, reported selling a total of 795 common shares on August 3 and 4, 2026, in two separate transactions, both executed under Rule 10b5-1 trading arrangements and related instructions.

How many Natera (NTRA) shares did the CFO sell on each transaction date?

On August 3, 2026, the CFO sold 317 shares at $267.9893 per share. On August 4, 2026, he sold 478 shares at $274.22 per share, for an aggregate of 795 shares sold across both days.

Why did Natera’s (NTRA) CFO sell 317 shares on August 3, 2026?

The 317-share sale on August 3, 2026 was executed to satisfy tax withholding and remittance obligations tied to the vesting of RSUs, under a written instruction intended to satisfy Rule 10b5-1(c) affirmative defense conditions.

What role does the insider in this Natera (NTRA) Form 4 hold?

The reporting person, Michael Burkes Brophy, serves as Chief Financial Officer of Natera, Inc. The reported transactions relate to his holdings of Natera common stock and associated RSU vesting tax obligations.

How many total Natera (NTRA) shares were sold by the CFO in this Form 4?

In this Form 4, the CFO is shown selling an aggregate of 795 shares of Natera common stock, consisting of 317 shares sold on August 3, 2026 and 478 shares sold on August 4, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brophy Michael Burkes

(Last)

(First)

(Middle)

C/O NATERA, INC.

13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)

AUSTIN

TEXAS

78753

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CHIEF FINANCIAL OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/03/2026		S		317⁽¹⁾	D	$267.9893	52,115	D
Common Stock	08/04/2026		S		478⁽²⁾	D	$274.22	51,637	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.

2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2025, as modified on September 10, 2025.

	/s/ Tami Chen, Attorney-in-Fact	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR